Table 1.
Patient demographics and clinical characteristics.
| Patient characteristics | N = 505(%) |
|---|---|
| Gender | |
| Male | 374 (74.1) |
| Female | 131 (25.9) |
| Age, years | |
| Mean ± SD | 47.41 ± 9.15 |
| <47 | 229 (45.3) |
| ≥47 | 276 (54.7) |
| BMI | |
| <18.5 | 30 (5.9) |
| 18.5 ~ 24 | 274 (54.3) |
| ≥24 | 201 (39.8) |
| Smoking status | |
| Smoker | 247 (48.9) |
| Nonsmoker | 258 (51.1) |
| Drinking status | |
| Drinker | 90 (17.8) |
| Nondrinker | 415 (82.2) |
| Histological type | |
| WHO type II | 214 (42.4) |
| WHO type III | 291 (57.6) |
| Clinical stage a | |
| I–II | 50 (9.9) |
| III–IV | 455 (90.1) |
| T-staging | |
| T1–T2 | 246 (48.7) |
| T3–T4 | 259 (51.3) |
| N-staging | |
| N0–N1 | 93 (18.4) |
| N2–N3 | 412 (81.6) |
| Grade 3–4 toxic reactions | |
| Dermatitis | 51 (10.1%) |
| Mucositis | 129 (25.5%) |
| Leukopenia | 73 (14.5%) |
| Neutropenia | 94 (18.6%) |
| Myelosuppression | 121 (24.0%) |
| IC regimen | |
| DP | 200 (39.6) |
| FP | 92 (18.2) |
| TP | 203 (40.2) |
| GP | 10 (2) |
| CRT regimen | |
| FP | 85 (16.8) |
| TP | 108 (21.4) |
| DDP | 83 (16.4) |
| NDP | 172 (34.1) |
| DP | 57 (11.3) |
| pGTVnx | |
| Mean ± SD | 71.34 ± 2.79 |
| <71.00 Gy | 261 (51.7) |
| ≥71.00 Gy | 234 (48.3) |
Abbreviations: BMI, Body Mass Index; IC regimen, Induction chemotherapy regimens; CRT regimen, concurrent chemoradiotherapy regimen; pGTVnx, irradiation dose.